Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $188.88M.
ENTERPRISE VALUE (EV)
$188.88M
Century Therapeutics, Inc.
Market Cap
$250.73M
Enterprise Value (EV)
$188.88M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $250.73M | $188.88M |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $251.16M | $235.26M |
| Q32 Bio Inc. (QTTB)vs › | $245.55M | $144.58M |
| Quantum-Si incorporated (QSI)vs › | $245.30M | $224.90M |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.09M | $242.99M |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.31M | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $242.27M | $233.39M |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.23M | $157.47M |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $259.38M | $141.51M |
| Galectin Therapeutics Inc. (GALT)vs › | $242.02M | $366.46M |
Market Cap
$250.73M
Total Debt
$0.00
Cash
$61.85M
Enterprise Value
$188.88M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
